Sort
15,842 grants matching “pancreatic cancer”
Mayo Clinic Hepatobiliary SPORE Diversity Supplement Dr. Musa Gabere
$136,012Mark A. Mc Niven · Mayo Clinic Rochester · P50 · FY2021 · CA
Metabolic targeting of cancer cells via the methylglyoxal detoxification systems
$136,000Daniel Tamae · California State University Northridge · SC2 · FY2019 · GM
REGULATION OF SMC/RMUC4 TRANSCRIPTION BY CELL SIGNALING
$135,817University Of Miami School Of Medicine · K01 · FY2002 · CA
Cancer Therapeutics Program
$135,765Caryn Lerman · University Of Pennsylvania · P30 · FY2014 · CA
Administration and Communication Core
$135,745Scott E Kern · Johns Hopkins University · P50 · FY2008 · CA
Defining lineage-specific determinants of K-Ras "addiction" in human cancers
$135,653Anurag Singh · Massachusetts General Hospital · K99 · FY2011 · CA
NUTRIENTS EFFECT ON GENOTYPE IN BREAST CANCER
$135,621Yale University · K08 · FY2003 · CA
Core C: Biobank Core
$135,612Sarah P Thayer · Dana-Farber Cancer Inst · P01 · FY2009 · CA
Institutional Career Development Core
$135,563John K Amory · University Of Washington · KL2 · FY2023 · TR
Integrin Contributions to Pancreatic Cancer
$135,549Kathleen L O'Connor · University Of Kentucky · R21 · FY2009 · CA
Molecular basis of pancreatic cancer progression and metastsis
$135,522Keping Xie · University Of Tx Md Anderson Can Ctr · R21 · FY2010 · CA
Molecular basis of pancreatic cancer progression and metastsis
$135,522Keping Xie · University Of Tx Md Anderson Can Ctr · R21 · FY2009 · CA
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer (Admin Supplement)
$135,521Santhi Swaroop Vege · Mayo Clinic Rochester · U01 · FY2023 · DK
Biostatistics and Bioinformatics Core Facility
$135,485Megan Orr · North Dakota State University · P20 · FY2022 · GM
Myofibroblasts in Gastrointestinal Cancers
$135,472Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2013 · CA
Nanoengineering Core
$135,460Mauro Ferrari · University Of Texas Hlth Sci Ctr Houston · U54 · FY2010 · CA
Bioinformatics, Statistical and Methodological Core
$135,394Enrique Israel Velazquez Villarreal · University Of Southern California · U54 · FY2019 · CA
Elucidating determinants of metastasis suppression in pancreatic cancer
$135,348Kaloyan M. Tsanov · Sloan-Kettering Inst Can Research · K99 · FY2023 · CA
Elucidating determinants of metastasis suppression in pancreatic cancer
$135,348Kaloyan M. Tsanov · Sloan-Kettering Inst Can Research · K99 · FY2022 · CA
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
$135,270Elisabeth M Zeisberg · Beth Israel Deaconess Medical Center · K08 · FY2008 · CA
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
$135,270Elisabeth M Zeisberg · Beth Israel Deaconess Medical Center · K08 · FY2009 · CA
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
$135,270Elisabeth M Zeisberg · Beth Israel Deaconess Medical Center · K08 · FY2011 · CA
Molecular and Cellular Origins of Pancreatic Cancer
$135,270Sunil R Hingorani · Fred Hutchinson Cancer Research Center · K08 · FY2007 · CA
Molecular and Cellular Origins of Pancreatic Cancer
$135,270Sunil R Hingorani · Fred Hutchinson Cancer Research Center · K08 · FY2008 · CA
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
$135,270Elisabeth M Zeisberg · Beth Israel Deaconess Medical Center · K08 · FY2010 · CA